Gland Pharma IPO is said to be the largest Pharma IPO in India. Isn’t that exciting? Hyderabad based Gland Pharma company is about to launch its IPO from 9th November 2020 to 11th November 2020. The Gland Pharma IPO size is said to be about Rs. 6480 Crores. The Grand Pharma IPO Grey Market Premium is surging, so do apply for this IPO.
Gland Pharma is one of the fastest-growing generic injectables-focused companies. Gland Pharma has seven manufacturing facilities in India, which includes four finished formulations facilities with a total of 22 production lines and three API facilities.
Gland Pharma IPO Review :
APPLY
Gland Pharma IPO Review
Gland Pharma IPO Date & Price Band :
| IPO Open: | 09 November 2020 |
| IPO Close: | 11 November 2020 |
| IPO Size: | Approx ₹6480 Crore |
| Price Band: | ₹1490 – ₹1500 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Equity: | 43,196,968 |
| Face Value: | ₹1 Per Equity Share |
Gland Pharma IPO Market Lot:
- Shares: Minimum 10 Shares & Maximum 130 Shares
- Minimum Amount: ₹15,000
- Maximum Amount: ₹1,95,000
Gland Pharma IPO Allotment & Listing :
- Basis of Allotment: 17 November 2020
- Refunds: 18 November 2020
- Credit to Demat accounts: 19 November 2020 Advertisement
- Listing: 20 November 2020
Gland Pharma IPO Form Download:
Thinking about how to apply the Gland Pharma IPO? Here is the answer, You can apply for Gland Pharma IPO through the ASBA feature of your bank. Login to your Net Banking option and go to Invest / IPO section. Select the Gland Pharma IPO, fill up and check the details and click submit. Another option to apply for Gland Pharma IPO is by submitting physical forms to your Bank. For that, you need to download forms – NSE Blank IPO Form / BSE Blank IPO Form, fill the details, and submit the form to the bank.
Gland Pharma Financial:
| (Rs. in Crore) | Revenue | Expense | PAT |
| 2016 | – | – | – |
| 2017 | – | – | – |
| 2018 | 1672 | 1170 | 321 |
| 2019 | 2130 | 1424 | 452 |
| 2020 | 2772 | 1780 | 768 |
Company Promoters:
- Fosun Pharma Industrial Pte. Ltd.
- Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Quick Links:
DRHP Draft Prospectus
RHP Draft Prospectus
Must Read:
Gland Pharma IPO Grey Market Premium
Gland Pharma IPO Subscription Live
Gland Pharma IPO Registrar:
Link Intime India Private Limited
C-101, 1stFloor, 247 Park,
Lal Bahadur Shastri Marg
Vikhroli (West) Mumbai,
Maharashtra 400 083
Tel: +91-22-4918 6270
E-mail: [email protected]
Website: www.linkintime.co.in
SEBI Registration No.: INR000004058
Note: Check Gland Pharma IPO allotment status on Linkintime website allotment URL. Click Here
Gland Pharma IPO Lead Managers:
- Citigroup Global Markets India Private Limited
- Haitong Securities India Private Limited
- Kotak Mahindra Capital Company Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
Company Address:
Gland Pharma Limited
Sy. No. 143 – 148, 150 and 151,
Near Gandi Maisamma ‘X’ Roads, D.P. Pally,Dundigal
Medchal-Malkajgiri District, Hyderabad
Phone: +91 40 3051 0999
Email: [email protected]
Website: http://www.glandpharma.com
Pingback: Gland Pharma IPO Subscription Data (Live) » IPO Guru
Pingback: Ajanta Pharma Buyback 2020 Review – Record Date, Price, and Details | Above Stocks